BLOG: Outlook for Allergan destined to change

Admit it. You went to ASCRS expecting to join your colleagues in the act of righteous indignation at the CMS data dump of physician Medicare income. I sure did. Boy, did THAT change fast when the news of Valeant and William Ackman teaming up to make a play for Allergan hit the front page of The Wall Street Journal on Tuesday before the meeting! I don’t know about you, but the only time the whole CMS nonsense came up was when another doc made the same observation that I just did. What do (Read more...)

Full Story →